Azerbaijan vs Turkmenistan: Average non-HDL cholesterol levels
Azerbaijan
3.3
in 2018
Turkmenistan
3.3
in 2018
Azerbaijan rank
95th
Turkmenistan rank
95th
Average non-HDL cholesterol levels over time
- Azerbaijan
- Turkmenistan
How they compare
Azerbaijan currently reports 3.3 against 3.3 in Turkmenistan, a difference of 0.
The two have swapped places 2 times across 39 shared years of data; in 1980 it was Turkmenistan ahead.
Azerbaijan ranks 95th and Turkmenistan ranks 95th of 191 countries.
Azerbaijan has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Azerbaijan | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.4 | 3.39 | 0.01 | Azerbaijan |
| 1990s | 3.32 | 3.3 | 0.02 | Azerbaijan |
| 2000s | 3.3 | 3.3 | 0 | — |
| 2010s | 3.3 | 3.3 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, Azerbaijan or Turkmenistan?
- Azerbaijan, at 3.3 against 3.3 in Turkmenistan as of 2018.
- What is the difference in average non-hdl cholesterol levels between Azerbaijan and Turkmenistan?
- 0, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Turkmenistan?
- 39 years are reported by both, from 1980 to 2018.
- How do Azerbaijan and Turkmenistan rank globally for average non-hdl cholesterol levels?
- Azerbaijan ranks 95th and Turkmenistan ranks 95th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.